about
Altered natural killer cell differentiation in CD34+ progenitors from chronic myeloid leukemia patientsUnderground Adaptation to a Hostile Environment: Acute Myeloid Leukemia vs. Natural Killer CellsEngagement of the inhibitory receptor CD158a interrupts TCR signaling, preventing dynamic membrane reorganization in CTL/tumor cell interactionDetection of a Ha-ras point mutation by polymerase chain reaction-single strand conformation polymorphism analysis in 2-amino-3,4-dimethylimidazo[4,5-f]quinoline-induced mouse forestomach tumorsMelanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015Chemokine receptor patterns in lymphocytes mirror metastatic spreading in melanoma.Serum soluble HLA-E in melanoma: a new potential immune-related marker in cancer.Generation of a novel regulatory NK cell subset from peripheral blood CD34+ progenitors promoted by membrane-bound IL-15Interleukin-15 plays a central role in human kidney physiology and cancer through the γc signaling pathway.Expression of IL-27 by tumor cells in invasive cutaneous and metastatic melanomas [corrected]..Tumor escape from killing: role of killer inhibitory receptors and acquisition of tumor resistance to cell death.Phenotypic and functional characteristics of blood natural killer cells from melanoma patients at different clinical stages.Classification of current anticancer immunotherapiesCharacterization of the Microenvironment in Positive and Negative Sentinel Lymph Nodes from Melanoma Patients.Consensus nomenclature for CD8(+) T cell phenotypes in cancerDetection of a functional hybrid receptor gammac/GM-CSFRbeta in human hematopoietic CD34+ cells.Dendritic cell and natural killer cell cross-talk: a pivotal role of CX3CL1 in NK cytoskeleton organization and activationIpilimumab reshapes T cell memory subsets in melanoma patients with clinical response.Phenotypic and Functional Dysregulated Blood NK Cells in Colorectal Cancer Patients Can Be Activated by Cetuximab Plus IL-2 or IL-15.NKp30 isoforms and NKp46 transcripts in metastatic melanoma patients: Unique NKp30 pattern in rare melanoma patients with favorable evolution.NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients.Prognostic impact of the expression of NCR1 and NCR3 NK cell receptors and PD-L1 on advanced non-small cell lung cancer.Immune Modifications in Fetal Membranes Overlying the Cervix Precede Parturition in Humans.Mutations of the von Hippel-Lindau gene confer increased susceptibility to natural killer cells of clear-cell renal cell carcinoma.Cytokeratin 18 expression pattern correlates with renal cell carcinoma progression: relationship with Snail.Human renal cancer cells express a novel membrane-bound interleukin-15 that induces, in response to the soluble interleukin-15 receptor alpha chain, epithelial-to-mesenchymal transition.Two opposite signaling outputs are driven by the KIR2DL1 receptor in human CD4+ T cells.Human CD5 protects circulating tumor antigen-specific CTL from tumor-mediated activation-induced cell death.The decreased susceptibility of Bcr/Abl targets to NK cell-mediated lysis in response to imatinib mesylate involves modulation of NKG2D ligands, GM1 expression, and synapse formation.Membrane-bound and soluble IL-15/IL-15Ralpha complexes display differential signaling and functions on human hematopoietic progenitors.Human NK cells lyse organ-specific endothelial cells: analysis of adhesion and cytotoxic mechanisms.Altered IFNgamma signaling and preserved susceptibility to activated natural killer cell-mediated lysis of BCR/ABL targets.Phosphostim-activated gamma delta T cells kill autologous metastatic renal cell carcinoma.Relevance of serum biomarkers associated with melanoma during follow-up of anti-CTLA-4 immunotherapy.Differential STAT3, STAT5, and NF-kappaB activation in human hematopoietic progenitors by endogenous interleukin-15: implications in the expression of functional molecules.Leukemic target susceptibility to natural killer cytotoxicity: relationship with BCR-ABL expression.NK cells differentiated from bone marrow, cord blood and peripheral blood stem cells exhibit similar phenotype and functions.In situ demonstration of renal-cell-carcinoma-specific T-cell clones.F11C antigen: a membrane marker able to distinguish two regressive and progressive variants from a rat colon adenocarcinoma.High number of CD56(bright) NK-cells and persistently low CD4+ T-cells in a hemophiliac HIV/HCV co-infected patient without opportunistic infections.
P50
Q22254246-2ED6ECC3-2EFE-469E-BFFE-45B3CA4D2DC9Q26751011-166133AA-6B65-4FF5-9E4D-E20B28F70253Q28204210-C91DE09F-9C3C-4D9D-9F0D-DE17C64E6CE3Q28319114-4B3D7524-E46D-4F5B-B204-BD2FC5E74DE8Q28553228-A068C55D-3659-46DA-900A-8A96B7D94F7BQ30358552-4719A688-0706-4F02-9142-BFCF1AD10423Q31021595-5E679C74-8770-4EE6-B4E6-003CCB2E8EA4Q33336590-6F23212C-4F49-4025-A0E5-A91EDC97EF98Q34171181-DD13F709-3076-47F1-B4B0-98CEF6B3CA35Q35018373-64758EF2-D09F-4744-9163-D7F2439CA35EQ35020684-FA6F964A-696E-4F1B-B1FC-764E7D2A82D9Q35034899-D3030E23-38D1-42AC-A906-96BFFA2205C5Q35149637-25601BDA-860A-4DC1-A9D3-68744DEBA5F1Q35719855-05267650-4345-4207-A723-EF6A23EBD98AQ35798822-61C088B0-955B-4B06-83FF-0BCD73CF5074Q36370615-BE2A3768-3018-4405-8A6F-58CEC92BFEE0Q37001936-907F31AB-9BAF-4D92-BEC7-ED1BEE7BE2B8Q37222127-6620491A-1B4C-4266-BC78-E560BCDDACF7Q37323344-6CD9E681-8CA7-42C6-8690-EFCEDF5336E7Q37558627-1103A7E0-20EA-4543-A92D-50612B130886Q37616478-701EDADB-44BD-4BF7-B30D-B9C7693A9A36Q37616484-DA8DE170-760C-4624-B58B-1FC52CE35B5AQ38777101-1FB1F096-810E-4783-B5BC-676D55C0525AQ39604051-726B6B5D-606C-48F3-ACB7-47E0F0F11433Q39717981-76FA9889-4252-412F-B565-6C0A14EB55D8Q39887901-F763339A-45FF-44CF-95D9-9C264A971773Q39968945-1EBE34E6-CF08-4BD5-B2D1-DDE5F00EDC22Q40130368-80AA2EE5-2DE8-472D-9EDF-5119EB0BEE86Q40333851-0A271558-A3B8-412B-9FF5-B4AE0461F011Q40405349-C9DC5E60-35C8-4A01-8530-8BA9A25CDFBFQ40432625-6FCC15B8-D416-4F4B-8B0B-C735E8DD41DDQ40439729-3D01D0DF-60E3-44E7-BD06-0EA25AAE68A4Q40468302-994CCE32-2B38-4A9F-8AA9-411D91E4989BQ40546307-54196F06-66CC-49A7-9D99-0620061D7E3BQ40665828-7FA47ECE-6E34-4D89-BD1D-81803063EA9BQ40747145-D6B17DE8-D1A4-4484-B8D9-ED5469F81510Q41030003-ED8BE371-C728-4195-866C-D71A30269136Q41198239-B7CF90BA-99FE-4B3A-A0F6-7F5A84E10855Q41718406-E8D8E034-82DA-4506-92CF-2800F9F5CBB2Q41878055-344426B5-3485-41DF-9EE4-44ACDB8CD2A2
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Anne Caignard
@ast
Anne Caignard
@en
Anne Caignard
@es
Anne Caignard
@fr
Anne Caignard
@nl
Anne Caignard
@sl
type
label
Anne Caignard
@ast
Anne Caignard
@en
Anne Caignard
@es
Anne Caignard
@fr
Anne Caignard
@nl
Anne Caignard
@sl
prefLabel
Anne Caignard
@ast
Anne Caignard
@en
Anne Caignard
@es
Anne Caignard
@fr
Anne Caignard
@nl
Anne Caignard
@sl
P214
P269
P106
P1412
P2038
Anne_Caignard
P21
P213
0000 0004 3240 8529
P214
P269
P2798
P31
P496
0000-0001-9923-6045
P735
P7859
viaf-216090726